P.A.M.), mucida@rockefeller.edu (D.M.) 15 16 Gut-brain connections monitor the intestinal tissue and its microbial and dietary content 1 , 17 regulating both intestinal physiological functions such as nutrient absorption and motility 2-4 , and 18 brain-wired feeding behaviour 3 . It is therefore plausible that circuits exist to detect gut microbes 19 and relay this information to central nervous system (CNS) areas that, in turn, regulate gut 20 physiology 5 . We characterized the influence of the microbiota on enteric-associated neurons (EAN) 21 by combining gnotobiotic mouse models with transcriptomics, circuit-tracing methods, and 22 functional manipulation. We found that the gut microbiome modulates gut-extrinsic sympathetic 23 neurons; while microbiota depletion led to increased cFos expression, colonization of germ-free 24 mice with short-chain fatty acid-producing bacteria suppressed cFos expression in the gut 25 sympathetic ganglia. Chemogenetic manipulations, translational profiling, and anterograde tracing 26 identified a subset of distal intestine-projecting vagal neurons positioned to play an afferent role in 27 microbiota-mediated modulation of gut sympathetic neurons. Retrograde polysynaptic neuronal 28 tracing from the intestinal wall identified brainstem sensory nuclei activated during microbial 29 depletion, as well as efferent sympathetic premotor glutamatergic neurons that regulate 30 gastrointestinal transit. These results reveal microbiota-dependent control of gut extrinsic 31 sympathetic activation through a gut-brain circuit.
1 sympathetic efferents, are equipped to sense multiple areas of the intestine simultaneously and transmit 2 information to other tissues and to the CNS, but also complement intrinsic EANs (iEAN) in the control of 3 gut function 6 . We sought to better characterize the connections of eEAN and whether their activity or 4 gene expression is influenced by the gut microbiota. To identify the location of eEAN cell bodies, we 5 injected a fluorescent retrograde tracer, cholera toxin beta subunit (CTB), into the wall of different 6 intestinal segments, and dissected extrinsic ganglia that project to the gut, specifically the sensory nodose 7 ganglion (NG) and dorsal root ganglia (DRG), as well as the sympathetic celiac-superior mesenteric (CG-8 SMG) ganglion ( Fig. 1a -c, Extended Data Fig. 1a-d) . Tracing specificity was confirmed by multiple 9 approaches including subdiaphragmatic vagotomy, tracing from unrelated organs, and selective intestinal 10 denervation (Extended Data Fig. 1e-p) . Individual CTB tracing of the duodenum, ileum, and colon 11 indicated that sensory and sympathetic innervation of these anatomically distinct intestinal regions is 12 mediated by non-overlapping neuronal cell populations ( Fig. 1d , Extended Data Fig. 1j-l) . These results 13 highlight the compartmentalization of both sensory and effector eEAN projecting to the intestine.
15
We characterized microbial-mediated EAN gene expression changes by transcriptionally profiling eEAN 16 ganglia identified by CTB-tracing using cell sorting-independent translating ribosomal affinity 17 purification (TRAP) 7 . We interbred pan-neuronal Snap25 Cre with Rpl22 lsl-HA (RiboTag) mice 8 , which 18 express a hemagglutinin (HA)-tagged ribosomal subunit 22, allowing for neuronal-specific 19 immunoprecipitation of actively translated polysome-bound mRNA from whole tissue homogenates, 20 avoiding possible confounding effects of neuronal dissociation on gene expression. Specific expression of 21 HA-tagged ribosomes in neurons was confirmed in different eEAN ganglia isolated from Snap25 RiboTag 22 mice (Extended Data Fig. 2a, b ). We performed TRAP-seq of the NG, thoracic 9 DRG, and CG-SMG 23 isolated from specific pathogen free (SPF) mice and Snap25 RiboTag mice re-derived into germ-free (GF) 24 conditions (Extended Data Fig. 2c, d ). Comparisons of eEAN nodes revealed significant enrichment of 25 transcripts associated with both sensory and sympathetic neurons 9 , validating our TRAP approach 26 (Extended Data Fig. 2c-h ). We did not observe significant changes in expression of actively-translated 27 genes in DRG between SPF and GF groups (Extended Data Fig. 2i ). However, gene ontology (GO) 28 analysis of the NG suggested an enrichment for genes associated with synaptic signalling and neuronal 29 activation in GF mice (Fig. 1e, f) . Additionally, the CG-SMG from GF animals displayed enriched GO 30 pathways for plasticity and signalling with significantly higher transcript levels of Fos (Fig. 1g, h) : a 31 classic neuronal immediate-early gene and indirect marker for neuronal activity, or plasticity (used 32 thereof interchangeably 10 ). Immunofluorescence analysis confirmed that CG-SMG isolated from GF mice 33 displayed significantly more cFos+ neuronal nuclei than their SPF mice counterparts (Fig. 1i, j, . Altogether these results point that absence of a microbiota results in elevated levels of 1 gut-extrinsic sympathetic activity.
3
To address whether specific microbes could mediate tonic suppression of CG-SMG neurons, we utilized 4 multiple microbial manipulation strategies. Faecal transfer from age-, sex-, strain-, and diet-matched SPF 5 donors into GF mice restored CG-SMG neuronal cFos to levels comparable to SPF conditions, suggesting 6 that microbiota can suppress gut-extrinsic sympathetic neurons (Fig. 2a ). The mere presence of live 7 bacteria was not enough to suppress CG-SMG neuronal activation, as evidenced by the comparable cFos 8 levels observed in GF mice mono-colonized with segmented filamentous bacteria and GF mice (Fig. 2b ).
9
However, colonization of GF mice with the defined altered-Schaedler-flora consortium (ASF) 11 or a 10 defined Clostridium spp. consortium 12 , was sufficient to suppress cFos expression in the CG-SMG ( Fig.   11 2b, c). Conversely, microbiota depletion of SPF mice for 2 weeks using broad-spectrum antibiotics 12 resulted in increased cFos+ neurons in the CG-SMG when compared to control mice ( Fig. 2d, e ).
13
Treatment with either ampicillin or vancomycin, but not with metronidazole or neomycin, was sufficient 14 to drive sympathetic cFos expression, suggesting that specific subsets of bacteria were able to suppress 15 cFos activation (Fig. 2f ). Additionally, a single oral gavage of streptomycin to SPF C57BL/6, BALB/c, or 16 CBA/J mice resulted in CG-SMG neuronal activation as early as 24 h post-gavage, as well as decrease in 17 microbiota diversity. Five days post streptomycin treatment, cFos levels in the CG-SMG returned to SPF 18 levels, indicating that gut-sympathetic activity is readily tuned to changes in the gut microbiota ( Fig. 2g,   19 Extended Data Fig. 2m, n) . Finally, to address whether activated CG-SMG sympathetic neurons project to 20 the intestine, we injected fluorescent CTB in the ileum of broad-spectrum antibiotic-treated Fos GFP mice.
21
We observed extensive colocalization between CTB+ (red) and cFos+ (green) neurons in the CG-SMG 22 ( Fig. 2h ), confirming that sympathetic neurons activated upon microbial depletion project to the intestine, 23 although we cannot exclude projections to other visceral tissue connected to the CG-SMG. The above 24 results indicate that a defined microbial consortium is sufficient to suppress cFos expression in gut 25 sympathetic neurons, and that sympathetic activity can reflect shifts in the gut microbial community.
27
We observed that gnotobiotic manipulations resulted in suppression of CG-SMG neurons when defined 28 microbial consortia, known to restore levels of SCFAs, were introduced [11] [12] [13] . Mass spectrometric 29 quantification of SCFAs confirmed that GF mice lacked detectable levels of butyrate, propionate, and 30 acetate in their cecal contents ( Fig. 2i ). GF mice colonized with ASF displayed a significant increase in 31 the levels of propionate and acetate in their ceca, while the Clostridium spp. consortium led to a 32 significant boost in butyrate and acetate levels ( Fig. 2i ). Furthermore, treatment with broad-spectrum 33 antibiotics, streptomycin, ampicillin or vancomycin alone recapitulated SCFA depletion to below 34 detection threshold . In each of these cases, the presence or absence of luminal SCFAs 1 correlated with the number of cFos+ neurons in the CG-SMG. In contrast, in the context of Salmonella 2 typhimurium infection, which we previously reported to induce CG-SMG activation 14 , we did not detect 3 significant changes in SCFAs at early stages of infection 15 , suggesting that additional signals contribute to 4 CG-SMG activation upon infection or in inflammatory contexts (Extended Data Fig. 3a-c) . Next, we 5 tested whether supplementation of SCFAs in microbiota-depleted mice restores cFos levels in their CG-6 SMG. Administration of exogenous butyrate, acetate, and propionate in the drinking water suppressed 7 streptomycin-induced cFos (Fig 2m) . Moreover, administration of tributyrin, a butyrate pro-drug 8 containing three acetylated butyrate molecules that are readily hydrolysed in the intestine 15,16 , was 9 sufficient to suppress cFos expression in CG-SMG neurons of both GF mice and SPF mice treated with 10 streptomycin ( Fig. 2n 
31
Consistent with the increase in cFos, we observed an increase in the percentage of gut-connected (PRV+) 32 TRAP+ cells in the LPGi/RVLM of these mice (Extended Data Fig. 7b ). To directly determine whether 33 these brainstem populations modulate gut-sympathetic activity, we bilaterally injected excitatory AAV5-DIO-hSyn-hM3Dq-mCherry into the Gi or the LPGi/RVLM of VGAT Cre and VGLUT2 Cre mice, 1 respectively (Extended Data Fig. 7c ). Designer Receptors Exclusively Activated by Designer Drugs 2 (DREADD) enable sustained chemogenetic modulation of neurons using the specific designer ligand 3 compound 21 (C21) 29 . C21 administration to wild-type or (Gi) VGAT mice did not affect baseline motility 4 measurements, but it significantly slowed intestinal transit and faecal pellet output in 5 (LPGi/RVLM) VGLUT2 mice ( Fig. 3l -q, Extended Data Fig. 7d-f ). As an additional control for the accurate 6 targeting of these brain regions 22 , C21 administration affected locomotion in both VGLUT2 and VGAT 7 groups (Extended Data Fig. 7g , h). Finally, consistent with a role for the excitatory nuclei upstream of 8 gut-sympathetic activation, chemogenetic activation of (LPGi/RVLM) VGLUT2 neurons, but not of (Gi) VGAT , 9 led to a significant increase in the number of cFos+ neurons in the CG-SMG ( Fig. 3r, s) . These findings 10 demonstrate that glutamatergic LPGi/RVLM brainstem neurons are capable of driving gut sympathetic 11 activity, which in turn can slow gastrointestinal transit.
13
We investigated further the ClearMap PRV-RFP analysis described above to identify additional brain 
18
(Extended Data Fig. 8a-d ). Previous studies demonstrated that the NTS and AP can directly integrate gut 19 sensory information from vagal sensory neurons or circulating factors 3, 32 and that these nuclei connect to 20 the LPGi/RVLM 33,34 . To determine whether changes in microbial load could affect neuronal activity in 21 the NTS and AP, we measured cFos in these areas after antibiotic treatment. Following streptomycin 22 treatment, we observed a significant increase in cFos expression in both the NTS and AP ( Fig. 4a , 23 Extended Data Fig. 8e ). These areas also displayed high levels of cFos in GF mice and Fos TRAP2:tdTomato 24 treated with streptomycin, further suggesting a functional relevance of these areas (Extended Data Fig. 8f -25 h). To assess whether these sensory brainstem nuclei are involved in the detection of SCFAs, we analysed 26 their cFos levels post administration of tributyrin to streptomycin-treated mice. While cFos levels in the 27 AP were suppressed, levels in the NTS remained elevated (Fig. 4b , Extended Data Fig. 8i ), suggesting the 28 AP as a distal sensory hub for intestinal SCFAs, although additional SCFA and unknown visceral signals 29 might be sensed in the NTS during dysbiosis or microbial depletion. These results characterize a set of 30 brainstem sensory nuclei tuned to detect changes in the gut microbiota or metabolites thereof.
32
The increased cFos expression in the NTS/AP upon microbial depletion suggests a functional role for 33 afferent sensory neurons in the regulation of gut sympathetic activity. Extrinsic neuronal sensing at the 34 intestinal epithelium, mucosa, and muscularis is primarily carried out by sensory afferents in the NG and 1 DRG 35 , both also identified by our retrograde strategies described above. To target NG or DRG sensory 2 activity we first crossed SNS Cre , a BAC-transgenic mouse expressing Cre under the Scn10a (Nav1.8) 3 promoter 36 , with inhibitory hM4Di (Rosa26 lsl-hM4Di ) mice. Therefore if afferent eEAN were involved in 4 this circuit, administration of C21 to SNS hM4Di mice should result in the inhibition of afferent eEAN 37 , 5 functionally phenocopying the loss of microbial signals and thus resulting in activation of gut sympathetic 6 neuron activation. We confirmed that SNS Cre recombination targets most DRG and NG neurons, in 7 addition to robust labelling of nerve fibres spanning the width of the intestinal wall (Extended Data Fig.   8 9a, b, Supplemental Table 1 ). Indeed, SNS hM4Di mice displayed a significant activation of CG-SMG 9 neurons upon administration of C21 ( Fig. 4c 
19
To narrow down the potential population of NG neurons targeted by these approaches, and their role in 20 this gut-brain-gut loop, we first isolated the NG from SNS RiboTag mice, the Cre line in which DREADD 21 modulation resulted in CG-SMG activation, or from Avil RiboTag and Nav1.8 RiboTag mice, i.e. Cre lines that 22 labelled subsets of NG neurons but were not affected by DREADD modulation (Extended Data Fig. 9g -i).
23
TRAP-seq analysis revealed a significant enrichment in the gene Scn5a (Nav1.5) in the NG of SNS RiboTag 24 mice when compared to either Avil RiboTag or Nav1.8 RiboTag mice (Fig. 4e, f) . Moreover, in situ hybridization 25 coupled with intestinal retrograde tracing confirmed that a proportion of gut-projecting NG are indeed 26 Nav1.5+ and targeted by SNS Cre mice ( Fig. 4g , Extended Data Fig. 9j -l). To address whether vagal 27 modulation can activate the sensory brainstem nuclei that we found to be modulated by microbiota 28 manipulation, we examined the NTS and AP of SNS hM4Di and Phox2b hM4Di mice treated with C21, and 29 observed significant increase in cFos (Extended Data Fig. 10a, b ). We chose this indirect measure of 30 vagal activity as reported markers of intrinsic NG activation in mice, such as phosphorylated ERK 40,41 , are 31 not well characterized and vagal nerve recordings lack the resolution required to detect physiologic 32 changes in afferent activity. We were not able to determine whether this increase in cFos is the result of 33 hM4Di activation or simply disinhibition of NTS/AP neurons. Additionally, we were unable to surgically assess the requirement of vagal sensory input to these areas, as sdVx alone led to a significant increase in 1 NTS/AP cFos (Extended Data Fig. 10c, d ). However, bilateral injection of fluorescent PRV into the 2 LPGi/RVLM confirmed that both connect to the NG ( 
16
The functional, circuit and gene expression-based studies presented here suggest that EAN detection of 17 microbes or their metabolites, either directly or indirectly via epithelial cells, is a core sensory system 18 whereby alterations in microbial composition is sufficient to significantly activate gut-projecting neurons.
19
Gut sympathetic activity can impact blood flow, motility, and epithelial secretion 25, 45 , which in turn may 20 influence microbial niches in the lumen. Activation of the gut-sympathetic nervous system following 21 microbial depletion may also explain the anti-inflammatory effects of specific types of antibiotics 46 .
22
Additional CG-SMG targets such as the spleen, pancreas, and liver may also be regulated by the 23 microbiota with conceivable impacts systemic immunity and metabolism. Furthermore, sympathetic 24 signalling can impact gene transcription in a variety of cell targets found in the intestine and elsewhere, 25 including gut-resident macrophages and innate lymphoid cells 14, 47 . Our data also suggests that a particular 26 population of gut-projecting vagal sensory neurons, enriched in transcript for the voltage gated sodium 27 channel Nav1.5, may play a role in mediating CNS-driven sympathetic suppression. It is intriguing to 28 note that mutations in Nav1. Tracing injections. Mice were anesthetized with 2% isoflurane with 1% oxygen followed by 1% 26 isoflurane with 1% oxygen to maintain anaesthesia. After shaving and sterilization of the abdomen, mice 27 were placed on a sterile surgical pad on top of a heating pad and covered with a sterile surgical drape.
28
Ophthalmic ointment was placed over the eyes to prevent dehydration and the incision site was sterilized.
29
Upon loss of recoil paw compression, a midline incision was made through the abdominal wall exposing 30 the peritoneal cavity. For injections into the CG-SMG or duodenum an additional incision was made 31 laterally to allow for better access. The duodenum, ileum, colon, or CG-SMG were located and exposed 32 for injection. All injections were made with a pulled glass pipette using a Nanoject III. Following 33 injection, the abdominal wall was closed using absorbable sutures and the skin was closed using surgical staples. Antibiotic ointment was applied to the closed surgical site and mice were given 0.05 mg/kg 1 buprenorphine every 12 h for 2 days. into the stomach or ileum to confirm successful vagotomy by a lack of labelling in the nodose ganglion.
24
Following the procedure, the abdominal wall was closed using absorbable sutures and the skin was closed 25 using surgical staples. Antibiotic ointment was applied to the closed surgical site and mice were given 26 0.05 mg/kg buprenorphine every 12 h for 2 days. For sham-operated animals the vagus nerve was 27 similarly exposed but not cut.
29
PRV tracing with sdVx. Mice were given sdVx as described above, followed by injection of a 1 µ L 30 mixture of (0.5 µ L PRV-152 and 0.5 µL CTB594) into the proximal colon. The inclusion of CTB was 31 necessary to confirm successful vagotomy and to ensure that nodose neurons observed came from 32 retrograde transport of PRV originating in the CG-SMG and traveling through the CNS. Antibiotic 33 ointment was applied to the closed surgical site and mice were given 0.05 mg/kg buprenorphine every 12 h for 2 days. For sham-operated animals the vagus nerve was similarly exposed but not cut. 
19
Cholera toxin tracing. Mice were anesthetized and operated on as described above. 1.5 uL of 1% CTB 20 488, 555, or 647 in PBS with 0.1% FastGreen was injected with a pulled glass pipette using a Nanoject III 21 into the ileum, duodenum, colon and celiac-superior mesenteric ganglion. For triple labelling, 0.5uL of 22 1% CTB488, 555, or 647 was injected into the duodenum, ileum, and proximal colon of the same mice.
23
The tissue was carefully washed several times with PBS to prevent possible spill over of tracer to other 24 tissues. Relevant tissues were then dissected after a minimum of 2-4 days post-injection.
26
Ileal denervation to confirm cholera toxin tracing specificity. Mice were anesthetized as described 27 above and the ileal vein and artery to the distal ileum was identified. A cauterizer was used to sever the 28 main ileal artery/vein and surrounding nerves. Once the mesentery was resected, 0.5uL of CTB594 with 29 0.1% FastGreen was injected with a pulled glass pipette using a Nanoject III was injected into the distal 30 ileum between the two most distal lymph nodes. The tissue was carefully washed several times with PBS 31 to prevent possible spill over of tracer to other tissues. LNG, RNG, and CG-SMG tissues were then 32 dissected after 2 days post-injection followed by overnight fixation in 4% PFA. Sham was identical to the 33 previous procedure, but the mesentery was left intact.
1 Nodose ganglion injection. Mice were anesthetized as described above and the ventral neck surface was 2 cut open. Associated muscle was removed by blunt dissection to expose the trachea. The NG was located 3 by following the vagus nerve along the carotid artery to the base of the skull. Fine forceps were used to 4 separate the vagus from the carotid artery, and the NG body was exposed by careful dissection. 1uL of 5 AAV9-Syn-ChrimsonR-tdTomato (Addgene #59171-AAV9) with 0.1% FastGreen was injected with a 6 pulled glass pipette using a Nanoject III. The skin was then closed with absorbable sutures and antibiotic 7 cream was applied. Relevant tissues were dissected at a minimum of 2 weeks post-injection. 
33
RiboTag. Heterozygous or homozygous Snap25 RPL22HA were used for TRAP-seq analysis as no 1 differences were found between either genotype. For NG, DRG, and CG-SMG IP, tissues were isolated as RNAScope. Nodose ganglia (NG) from C57Bl/6 mice were dissected as described above. Once removed 8 ganglia were dipped in Fast Green (1%, Sigma-Aldrich) to assist with visualization when slicing and flash 9 frozen in OCT. 15 um sections of NG were sliced on a cryostat for RNAScope. Samples were processed 10 and stained with Scn5a, positive control or negative control probes according to the manufacturer's 11 instructions. Samples were mounted in Prolong gold antifade with DAPI (Thermo-Fisher) for imaging 12 and imaged within 24 hours on an inverted LSM 880 NLO laser scanning confocal and multiphoton 13 microscope (Zeiss) and images were processed using Image J.
15
RNAScope/IHC. C57Bl/6 mice were injected bilaterally with CTB 488 into the colon as described 16 above. NG were dissected 1 week post injection as described above, dipped in Fast Green (1%, Sigma-17 Aldrich) to assist with visualization and flash frozen in OCT. 15 um sections of NG were sliced on a 18 cryostat for RNAScope/IHC. Samples were processed and stained with Scn5a, positive or negative 19 control probes according to the manufacturer's instructions. After in situ hybridization sections were 20 washed three times in wash buffer (1X, ACDBio) and then fixed in 1% PFA in TBS for 10 minutes at 4 C 21 to stabilize the ISH labeling. Samples were next washed three times in TBS-T and incubated in 10%
22
Goat Serum in TBS with 1% BSA for 30 minutes. Samples were stained with anti Alexafluor-488 23 antibody (1:500, Thermo-Fisher) for 1 hour in TBS-1% BSA. After primary antibody staining, sections 24 were washed three times for 5 minutes each in TBST and stained with Goat anti rabbit AF488 (1:500,
25
Thermo-Fisher) in TBS-1% BSA for 30 minutes. Samples were again washed three times for 5 minutes 26 each in TBST and finally mounted in Prolong gold antifade with DAPI (Thermo-Fisher) for imaging.
27
Slides were imaged within 24 hours of mounting on an inverted LSM 880 NLO laser scanning confocal 28 and multiphoton microscope (Zeiss) and images were processed using Image J.
30
Intestine motility measurements. For measurement of total intestinal transit time, mice were given an 31 oral gavage of 6% carmine red dissolved in 0.5% methylcellulose (made with sterile 0.9% saline). Total 32 intestinal transit time was measured as the time from oral gavage it took for mice to pass a fecal pellet that 33 contained carmine. To measure colonic motility a glass bead (3 mm diameter) was pushed into the colon 34 to a distance of 2 cm from the anal verge. The time required for expulsion of the glass bead was measured 1 and taken as an estimate of colonic motility. Mice in both assays were injected 2 minutes before starting 2 with i.p. Compound 21 (1mg/kg or 10mg/kg as indicated). 
27
Cecal butyrate measurements. Concentrations of acetate, propionate, and butyrate were measured as 28 previously described 59 . Briefly murine cecal content samples were collected directly into Bead-Ruptor 29 tubes with 2.8-mm ceramic beads (OMNI International) and immediately frozen on dry ice. After 30 thawing, samples were extracted with 80% methanol containing internal standards of deuterated SCFA 31 (d-3 acetate, d-5 propionate, and d-7 butyrate; Cambridge Isotope Laboratories). Pellets were resuspended 32 at a ratio of 100 mg/ml and homogenized. Homogenized samples were centrifuged at 20,000 g for 15 min 33 at 4°C. The supernatant was derivatized for 60 min at 65°C with one volume of 50 mM, pH 11.0 borate
